Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2012 2
2013 2
2014 2
2016 1
2017 1
2018 2
2019 3
2020 3
2021 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Interferon-ε is a tumour suppressor and restricts ovarian cancer.
Marks ZRC, Campbell NK, Mangan NE, Vandenberg CJ, Gearing LJ, Matthews AY, Gould JA, Tate MD, Wray-McCann G, Ying L, Rosli S, Brockwell N, Parker BS, Lim SS, Bilandzic M, Christie EL, Stephens AN, de Geus E, Wakefield MJ, Ho GY, McNally O; Australian Ovarian Cancer Study; McNeish IA, Bowtell DDL, de Weerd NA, Scott CL, Bourke NM, Hertzog PJ. Marks ZRC, et al. Among authors: bilandzic m. Nature. 2023 Aug;620(7976):1063-1070. doi: 10.1038/s41586-023-06421-w. Epub 2023 Aug 16. Nature. 2023. PMID: 37587335
Betaglycan: a multifunctional accessory.
Bilandzic M, Stenvers KL. Bilandzic M, et al. Mol Cell Endocrinol. 2011 Jun 6;339(1-2):180-9. doi: 10.1016/j.mce.2011.04.014. Epub 2011 Apr 28. Mol Cell Endocrinol. 2011. PMID: 21550381 Review.
Therapeutic Targeting of Collective Invasion in Ovarian Cancer.
Moffitt L, Karimnia N, Stephens A, Bilandzic M. Moffitt L, et al. Among authors: bilandzic m. Int J Mol Sci. 2019 Mar 22;20(6):1466. doi: 10.3390/ijms20061466. Int J Mol Sci. 2019. PMID: 30909510 Free PMC article. Review.
Reprint of: Betaglycan: a multifunctional accessory.
Bilandzic M, Stenvers KL. Bilandzic M, et al. Mol Cell Endocrinol. 2012 Aug 15;359(1-2):13-22. doi: 10.1016/j.mce.2012.03.020. Epub 2012 Apr 13. Mol Cell Endocrinol. 2012. PMID: 22521265
Chemoresistance is mediated by ovarian cancer leader cells in vitro.
Karimnia N, Wilson AL, Green E, Matthews A, Jobling TW, Plebanski M, Bilandzic M, Stephens AN. Karimnia N, et al. Among authors: bilandzic m. J Exp Clin Cancer Res. 2021 Sep 1;40(1):276. doi: 10.1186/s13046-021-02086-3. J Exp Clin Cancer Res. 2021. PMID: 34470672 Free PMC article.
Discovery and Validation of Novel Protein Biomarkers in Ovarian Cancer Patient Urine.
Sandow JJ, Rainczuk A, Infusini G, Makanji M, Bilandzic M, Wilson AL, Fairweather N, Stanton PG, Garama D, Gough D, Jobling TW, Webb AI, Stephens AN. Sandow JJ, et al. Among authors: bilandzic m. Proteomics Clin Appl. 2018 May;12(3):e1700135. doi: 10.1002/prca.201700135. Epub 2018 Mar 2. Proteomics Clin Appl. 2018. PMID: 29426060
22 results